Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028961 · ClinicalTrials.gov registry record · NA
Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT03028961: Completed NA study, sponsored by Stanford University.
NCT03028961 is a NA study that has completed, run by Stanford University. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028961, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive. Completion of advance care planning prior to BMT is very important, but not often done. The investigators believe that the Stanford Letter will be preferred by patients and will allow them to feel more comfortable and share more of their wishes with family members and the medical team.
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
- OTHER Stanford Letter
- OTHER CA Advance Health Care Directive Form
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2021-07-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028961
The ClinicalTrials.gov registry entry for NCT03028961 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT03028961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03028961 about?
NCT03028961 is a clinical study titled "Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant". The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive. Completion of advance care planning prior to BMT is very important, but not often done. The investigators believ...
What is the current status of trial NCT03028961?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2017-03-03. Estimated completion is 2021-07-27.
What interventions are being tested in trial NCT03028961?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Stanford Letter (OTHER), CA Advance Health Care Directive Form (OTHER).
Who is sponsoring clinical trial NCT03028961?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.